Generation of reactive oxygen metabolites by the varicose vein wall

European Journal of Vascular and Endovascular Surgery

Volumn 23, Issue 6, 2002, Pages 550-555

  Glowinski, J ^a   Glowinski, S ^a,b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Department of Vascular Surgery and Transplantology ^*  (Poland)

Author keywords

Free radicals; Neutrophil activation; Varicose vein; Xanthine oxidase

Indexed keywords

MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; XANTHINE OXIDASE; PEROXIDASE;

ADULT; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL; SAPHENOUS VEIN; THROMBOPHLEBITIS; TISSUE HOMOGENATE; VARICOSIS; VASA VASORUM; VEIN SURGERY; CHEMISTRY; COMPARATIVE STUDY; IN VITRO STUDY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADULT; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; PEROXIDASE; REACTIVE OXYGEN SPECIES; SAPHENOUS VEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THROMBOPHLEBITIS; VARICOSE VEINS; XANTHINE OXIDASE;

EID: 0036598459     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1053/ejvs.2002.1656     Document Type: Article

References (33)

1. CLARKE GH, VASDEKIS SN, HOBBS JT, NICOLAIDES AN. Venous wall function in the pathogenesis of varicose veins. Surgery 1992; 111: 402-408.
2. MICHIELS C, ARNOULD T, REMACLE J. Hypoxia induced activation of endothelial cells as a possible cause of venous diseases: Hypothesis. Angiology 1993; 44: 639-646.
3. RATYCH RE, CHUKNYISKA RS, BULKLEY GB. The primary localization of free radical generation after anoxia/reoxygenation in isolated endothelial cells. Surgery 1987; 102: 122-131.
4. ZWEIER JL, KUPPUSAMY P, GORMAN-THOMSON S, KLUNK D, LUTTY GA. Measurement and characterization of free radical generation in reoxygenated human endothelial cells. Am J Physiol 1994; 266: C700-C708.
5. COLERIDGE-SMITH PD, THOMAS P, SCURR JH, DORMANDY JA. Causes of venous ulceration: a new hypothesis. Br Med J 1988; 296: 1726-1727.
6. CIUFFETTI G, MANNARINO E, PALTRICCIA R et al. Leucocyte activity in chronic venous insufficiency. Int Angiol 1994; 13: 312-316.
7. TAKASE S, SCHMID-SCHONBEIN G, BERGAN JJ. Leukocyte activation in patients with venous insufficiency. J Vasc Surg 1999; 30: 148-156.
8. ONO T, BERGAN JJ, SCHMID-SCHÖNBEIN GW, TAKASE S. Monocyte infiltration into venous valves. J Vasc Surg 1998; 27: 158-166.
9. BRADBURY AW, MURIE JA, RUCKLEY CV. Role of the leucocyte in the pathogenesis of vascular disease. Br J Surg 1993; 80: 1503-1512.
10. SCHMEKEL B, KARLSSON SE, LINDEN M et al. Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation 1990; 14: 447-454.
11. PHAN SH, GANNON DE, WARD PA, KARMIOL S. Mechanism of neutrophil-induced xanthine dehydrogenase to xanthine oxidase conversion in endothelial cells: evidence of a role for elastase. Am J Respir Cell Mol Biol 1992; 6: 270-278.
12. SALIM AS. The role of oxygen-derived free radicals in the management of venous (varicose) ulceration: a new approach. World J Surg 1991; 15: 264-269.
13. BUEGE JA, AUST SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 51: 302-310.
14. ESTERBAUER H, CHEESEMAN KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-421.
15. SATO Y, MUKAI K, WATANABE S, GOTO M, SHIMOSATO Y. The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol 1986; 125: 431-435.
16. PETRUZZO P, CAPPAI A, BROTZU G et al. Lipid metabolism and molecular changes in normal and atherosclerotic vessels. Eur J Vasc Endovasc Surg 2001; 22: 31-36; doi:10.1053/ejvs.2001.1378.
17. BELCARO G, NICOLAIDES AN, ERRICHI BM et al. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study. Angiology 1999; 50: 523-529.
18. HANSON JN, ASCHER E, DEPIPPO P et al. Saphenous vein thrombophlebitis (SVT): a deceptively benign disease. J Vasc Surg 1998; 27: 677-680.
19. TRAVERS JP, BROOKES CE, EVANS J et al. Assessment of wall structure and composition of varicose veins with reference to collagen, elastin and smooth muscle content. Eur J Vasc Endovasc Surg 1996; 11: 230-237.
20. KOCKX MM, KNAAPEN MW, BORTIER HE et al. Vascular remodeling in varicose veins. Angiology 1998; 49: 871-877.
21. YAMADA T, TOMITA S, MORI M, SASATOMI E, SUENAGA E, ITOH T. Increased mast cell infiltration in varicose veins of the lower limbs: a possible role in the development of varices. Surgery 1996; 119: 494-497.
22. REILLY PM, SCHILLER HJ, BULKLEY GB. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 1991; 161: 488-503.
23. RUBANYI GM. Vascular effects of oxygen-derived free radicals. Free Radic Biol Med 1988; 4: 107-120.
24. WIENTJES FB, SEGAL AW. NADPH oxidase and the respiratory burst. Semin Cell Biol 1995; 6: 357-365.
25. JAESCHKE H. Mechanism of oxidant stress-induced acute tissue injury. Proc Soc Exp Biol Med 1995; 209: 104-111.
26. FARBISZEWSKI R, GLOWINSKI J, MAKAREWICZ-PLONSKA M, OSTAPOWICZ R, GLOWINSKI S. Oxygen-derived free radicals as mediators of varicose vein wall damage. Vasc Surg 1996; 30: 47-52.
27. TANAKA H, OKADA T, KONISHI H, TSUJI T. The effect of reactive oxygen species on the biosynthesis of collagen and glycosaminoglycans in cultured human dermal fibroblasts. Arch Dermatol Res 1993; 285: 352-355.
28. GANDHI RH, IRIZARRY E, NACKMAN GB et al. Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. J Vasc Surg 1993; 18: 814-820.
29. CARR AC, MCCALL MR, FREI B. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler Thromb Vasc Biol 2000; 20: 1716-1723.
30. DAVIDSON JM, LUVALLE PA, ZOIA O, QUAGLINO D, GIRO M. Ascorbate differentially regulates elastin and collagen biosynthesis in vascular smooth muscle cells and skin fibroblasts by pretranslational mechanisms. J Biol Chem 1997; 272: 345-352.
31. BERGAN JJ, Schmid-SCHONBEIN GW, TAKASE S. Therapeutic approach to chronic venous insufficiency and its complications: place of Daflon 500 mg. Angiology 2001; 52: S43-S47.
32. DE-GROOT H, RAUEN U. Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharmacol 1998; 12: 249-255.
33. ARNOULD T, JANSSENS D, MICHIELS C, REMACLE J. Effect of aescine on hypoxia-induced activation of human endothelial cells. Eur J Pharmacol 1996; 315: 227-233.